Skip to main navigation
Skip to search
Skip to main content
Sort by:
Keyphrases
Active Components
12%
Antitumor Activity
12%
Assay Kit
12%
Axillary Lymph Node
25%
B16F10 Cells
12%
C57BL
12%
Chinese Medicinal Herbs
12%
Cyclophosphamide
12%
Flow Cytometric Analysis
12%
Forkhead Box P3 (FOXP3)
25%
Group Model
12%
Growth Productions
12%
High Dose
12%
Immunosorbent Assay
12%
Inhibit Tumor
12%
Interleukin-10
100%
Melanoma
100%
MRNA Level
25%
Peripheral Blood
12%
Quantitative PCR
12%
Regulatory T (Treg) Cells
100%
Regulatory T Cells
62%
Spleen
50%
Transforming Growth Factor-β
75%
Treatment Group
12%
Tripterygium Wilfordii
12%
Triptolide
100%
Tumor Growth
12%
Tumor Immunity
12%
Tumor Tissue
12%
Tumor-bearing Mice
37%
Vascular Endothelial Growth Factor
62%
Medicine and Dentistry
Antineoplastic Activity
12%
Axillary Lymph Node
25%
C57BL/6
12%
Cancer Growth Factor
75%
Cyclophosphamide
12%
Cytokine
25%
Drug Megadose
12%
Enzyme Linked Immunosorbent Assay
12%
Interleukin 10
100%
Low Drug Dose
12%
Melanoma
100%
Messenger RNA
25%
Neoplasm
50%
Real Time Polymerase Chain Reaction
12%
Regulatory T Cell
62%
Spleen Lymph Node
25%
Treatment Group
12%
Tripterygium wilfordii
12%
Triptolide
100%
Tumor Immunity
12%
Tumor Progression
12%
Vasculotropin
100%
Pharmacology, Toxicology and Pharmaceutical Science
Antitumor Activity
12%
C57BL 6 Mouse
12%
Cancer Growth Factor
75%
Cyclophosphamide
12%
Cytokine
25%
Interleukin 10
100%
Melanoma
100%
Messenger RNA
25%
Neoplasm
62%
Treatment Group
12%
Tripterygium wilfordii
12%
Triptolide
100%
Tumor Growth
12%
Vasculotropin
100%
Immunology and Microbiology
Antineoplastic Activity
14%
Axillary Lymph Node
28%
C57BL 6 Mouse
14%
Cancer Growth Factor
85%
Cyclophosphamide
14%
Cytokine
28%
Drug Megadose
14%
Immunoadsorption
14%
Interleukin 10
100%
Low Drug Dose
14%
Real Time Polymerase Chain Reaction
14%
Regulatory T Cell
100%
Spleen Lymph Node
28%
Tripterygium wilfordii
14%
Tumor Immunity
14%
Vasculotropin
100%